Biomarker Analysis Contextualizes RFS Benefit With Nivolumab in Metastatic Melanoma
Brian Gastman MD,
Source: onclive.com
Stay updated with breaking news from Quest Imaging. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Brian Gastman MD,
Immune checkpoint inhibitor retreatment in advanced melanoma is used in clinical practice, but there is a lack of evidence to support it.